Townsend & Associates, Inc Amgen Inc Transaction History
Townsend & Associates, Inc
- $917 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding AMGN
# of Institutions
3,172Shares Held
419MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.2 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.2 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.07 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.49 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.07 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $165B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...